A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial
Clinical trial NCT01839279 · COMPLETED
Trial details
- NCT number
- NCT01839279
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-02-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.